abstract |
Compounds of formula (I) are provided which are useful in the treatment of diseases or conditions modulated at least in part by CCR6. Pharmaceutical compositions of the compounds of formula (I) are also provided. Further provided in the present disclosure preparative methods for the synthesis of compounds of formula (I), as well as selected intermediates useful in the preparation. |